bupropion has been researched along with tromethamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arjona-Padillo, A; De la Torre-Colmenero, JD; Fernandez-Perez, J | 1 |
1 review(s) available for bupropion and tromethamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for bupropion and tromethamine
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion].
Topics: Apraxias; Bupropion; Calcium Channel Blockers; Carotid Stenosis; Cerebral Arteries; Cerebrovascular Disorders; Drug Substitution; Female; Gait Disorders, Neurologic; Headache Disorders, Primary; Humans; Ketoprofen; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Nimodipine; Personality Disorders; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tension-Type Headache; Tromethamine; Vasoconstriction | 2018 |